Department of Medical Biology and Genetics, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Department of Biology, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Front Endocrinol (Lausanne). 2023 Oct 20;14:1181064. doi: 10.3389/fendo.2023.1181064. eCollection 2023.
AIM/INTRODUCTION: The study aimed to determine the effectiveness of early antidiabetic therapy in reversing metabolic changes caused by high-fat and high-sucrose diet (HFHSD) in both sexes.
Elderly Sprague-Dawley rats, 45 weeks old, were randomized into four groups: a control group fed on the standard diet (STD), one group fed the HFHSD, and two groups fed the HFHSD along with long-term treatment of either metformin (HFHSD+M) or liraglutide (HFHSD+L). Antidiabetic treatment started 5 weeks after the introduction of the diet and lasted 13 weeks until the animals were 64 weeks old.
Unexpectedly, HFHSD-fed animals did not gain weight but underwent significant metabolic changes. Both antidiabetic treatments produced sex-specific effects, but neither prevented the onset of prediabetes nor diabetes.
Liraglutide vested benefits to liver and skeletal muscle tissue in males but induced signs of insulin resistance in females.
目的/引言:本研究旨在确定早期抗糖尿病治疗在逆转高脂肪和高蔗糖饮食(HFHSD)引起的代谢变化方面对雌雄两性的有效性。
45 周龄老年 Sprague-Dawley 大鼠随机分为四组:标准饮食喂养的对照组(STD)、HFHSD 喂养组、以及 HFHSD 喂养同时长期给予二甲双胍(HFHSD+M)或利拉鲁肽(HFHSD+L)治疗的两组。抗糖尿病治疗在饮食引入后 5 周开始,持续 13 周,直至动物 64 周龄。
出乎意料的是,HFHSD 喂养的动物体重未增加,但发生了显著的代谢变化。两种抗糖尿病治疗均产生了性别特异性的作用,但均不能预防糖尿病前期或糖尿病的发生。
利拉鲁肽赋予雄性肝脏和骨骼肌组织益处,但诱导雌性出现胰岛素抵抗迹象。